Chemoinformaics analysis of 9,10-Phenanthrenequinone
Molecular Weight | 208.216 | nRot | 0 |
Heavy Atom Molecular Weight | 200.152 | nRig | 21 |
Exact Molecular Weight | 208.052 | nRing | 3 |
Solubility: LogS | -6.931 | nHRing | 0 |
Solubility: LogP | 7.421 | No. of Aliphatic Rings | 1 |
Acid Count | 0 | No. of Aromatic Rings | 2 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
Atoms Count | 24 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 16 | No. of Aromatic Carbocycles | 2 |
nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 8 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 14 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 12 |
No. of Oxygen atom | 2 | No. of Arom Bond | 12 |
nHA | 2 | APOL | 30.3183 |
nHD | 0 | BPOL | 9.76166 |
QED | 0.421 |
Synth | 4.491 |
Natural Product Likeliness | 2.744 |
NR-PPAR-gamma | 0.009 |
Lipinski | Accepted |
Pfizer | Rejected |
GSK | Rejected |
Golden Triangle | Rejected |
Pgp-inh | 0.314 |
Pgp-sub | 0 |
HIA | 0.004 |
CACO-2 | -4.733 |
MDCK | 0.00000805 |
BBB | 0.617 |
PPB | 0.98652 |
VDSS | 3.997 |
FU | 0.0140804 |
CYP1A2-inh | 0.083 |
CYP1A2-sub | 0.499 |
CYP2c19-inh | 0.076 |
CYP2c19-sub | 0.907 |
CYP2c9-inh | 0.125 |
CYP2c9-sub | 0.582 |
CYP2d6-inh | 0.013 |
CYP2d6-sub | 0.902 |
CYP3a4-inh | 0.34 |
CYP3a4-sub | 0.531 |
CL | 11.532 |
T12 | 0.013 |
hERG | 0.056 |
Ames | 0.025 |
ROA | 0.02 |
SkinSen | 0.113 |
Carcinogencity | 0.083 |
EI | 0.01 |
Respiratory | 0.661 |
NR-Aromatase | 0.552 |
Antiviral | No |
Prediction | 0.704749 |